Correlation between left ventricular diastolic function and plasma natriuretic peptide level in children with pulmonary artery hypertension secondary to congenital heart disease
CUI Hua, HU Yi-Xin, FENG Zhi-Chun
Second Department of Cardiology, General Hospital of People′s Liberation Army, Beijing 100853, China. Email: bjcuihua@yahoo.com.cn
Abstract:OBJECTIVE: To study the plasma natriuretic peptide (BNP) level in children with pulmonary artery hypertension (PAH) secondary to congenital heart disease (CHD) and its correlation with left ventricular diastolic function. METHODS: Doppler echocardiography was performed on 95 CHD children with PAH (PAH group) and on 42 CHD without PAH (control group). The plasma BNP level was measured using radioimmunity assay. RESULTS: Doppler echocardiography showed that the left ventricular end-diastolic diameter (LVDd), the right ventricular diameter end-diastolic (RVDd), and the pulmonary artery diameter (PAd) increased significantly in the PAH group compared with those in the control group (P<0.05). The PAH group had higher velocity of tricuspid regurgitation (VTR) and higher pulmonary artery systolic pressure (PASP) than the control group (P<0.05). The PAH group also had higher mitral A peak velocity (AV), higher mitral A peak velocity integral (AVI), higher E peak velocity intgral (EVI), and higher ratio of mitral AV to mitral E peak velocity (EV) and AVI/EVI ratio as well as prolonged left ventricular volumetric relaxation time than the control group. PASP was positively correlated with the AV/EV ratio (P<0.05). The plasma BNP level in the PAH group increased significantly compared with that in the control group. In the PAH group, the plasma BNP level was positively correlated with the pulmonary artery pressure and the ratio of AV/EV. CONCLUSIONS: The left ventricular diastolic function is positively correlated with the plasma BNP level in children with PAH secondary to CHD. BNP may play an important role in the generation and development of left ventricular diastolic dysfunction induced by PAH.[Chin J Contemp Pediatr, 2010, 12 (1):13-16]
CUI Hua,HU Yi-Xin,FENG Zhi-Chun. Correlation between left ventricular diastolic function and plasma natriuretic peptide level in children with pulmonary artery hypertension secondary to congenital heart disease[J]. CJCP, 2010, 12(1): 13-16.
[1]Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure[J]. Endocr Rev, 2003, 24(5):341-356.
[2]Stephen B, Dalal P, Berger M, Schweitzer P, Hecht S. Noninvasive estimation of pulmonary artery diastolic pressure in patients with tricuspid regurgitation by Doppler echocardiography[J]. Chest, 1999, 116(1):73-77.
[3]Currie PJ, Seuard JB, Chan KJ, Coplu L, Diaz S. Continuous wave Doppler determination of right ventricular pressure a simultaneous Doppler catheterization study in 127 patients[J]. J Am Coll Cardiol, 1985, 6(4):750-756.
[5]Jessup M, Sutton MS, Weber KT, Janicki JS.The effect of chronic pulmonary hypertension on left ventricular size,function and interventricular septal motion[J]. Am Heart J, 1987, 113(5):1114-1122.
[8]Ozer N, Tokgozoglu L, Coplu L, Kes S. Echocardiographic evaluation of left and right ventricular diastolic function in patients with chronic obstructive pulmonary disease[J]. J Am Soc Echocardiogr, 2001, 14(6):557-561.
[9]Mahmud E, Raisinghani A, Hassankhani A, Sadeghi HM, Strachan GM, Auger W, et al. Correlation of left ventricular diastolic filling characteristics with right ventricular overload and pulmonary artery pressure in chronic thromboembolic pulmonary hypertension[J]. J Am Coll Cardiol, 2002, 40(2):318-324.
[10]Munagala VK, Burnett JC Jr, Redfield MM. The natriuretic peptides in cardiovascular medicine[J]. Curr Probl Cardiol, 2004, 29(12):707-769.
[11]Betti I, Castelli G, Barchielli A, Beligni C, Boscherini V, De Luca L, et al. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study[J]. J Card Fail, 2009, 15(5):377-384.
[12]Favilli S, Frenos S, Lasagni D, Frenos F, Pollini I, Bernini G, et al. The use of B-type natriuretic peptide in paediatric patients: a review of literature[J]. J Cardiovasc Med (Hagerstown), 2009, 10(4):298-302.
[13]Cantinotti M, Vittorini S, Storti S, Prontera C, Murzi M, De Lucia V, et al. Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases[J]. J Cardiovasc Med (Hagerstown), 2009, 13(1):56-63.
[14]Bernus A, Wagner BD, Accurso F, Doran A, Kaess H, Ivy DD. Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension[J]. Chest, 2009, 135(3):745-751.
[15]Leuchte HH, Holzapfel M, Baumgartner RA, Neurohr C, Vogeser M, Behr J.Characterization of brain natriuretic peptide in long-term followup of pulmonary arterial hypertension[J]. Chest, 2005, 128(4):2368-2374.
[16]Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease[J]. Eur Heart J, 2006, 27(7):861-866.